DDW 2020: Apixaban Has Lower Risk of Major Gastrointestinal Bleeding than Other DOACs, Suggests Meta-Analysis
Other DOACs have a higher risk of major gastrointestinal bleeding at standard doses than warfarin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.